Equitiesbullish4 min read
Brazil's Patent Debate: Semaglutide Expiration, INPI Delays & Pharma Impact
Brazil's drug patent system faces renewed scrutiny following the semaglutide patent expiration, highlighting the social cost of extended patent terms due to INPI processing delays.